DoW Arthritis Translational Research Award
About
Summary: The fiscal year 2026 (FY26) Arthritis Research Program (ATRP) Translational Research Award (TRA) supports high-impact translational research that will accelerate critical findings into clinically relevant solutions. Research funded under this award mechanism will be hypothesis-driven, high-impact applied research that is relevant to Service Members, Veterans, their Families and the American public. Research addressing any and all types of arthritis is encouraged. Distinctive Features: The FY26 ATRP TRA mechanism is intended to support preclinical or animal research and may not be used for clinical research or clinical trials. Basic research, as defined in Section 3.1.2, is not allowed. A key aspect of this award mechanism is impact. The application should explicitly state how outcomes of the proposed research will significantly advance arthritis research, particularly in accelerating critical findings into clinically relevant solutions. Preliminary and/or published data, originating from research conducted by the applicant(s) or others, is required.
The DoW Arthritis Translational Research Award (TRA) is a fiscal year 2026 funding opportunity designed for researchers committed to converting arthritis research discoveries into real-world clinical solutions. This award supports high-impact translational research that bridges the gap between laboratory findings and practical applications benefiting Service Members, Veterans, their families, and the American public. The program funds hypothesis-driven, applied research across all arthritis types, with a strategic focus on accelerating the pathway from research to clinical relevance. Researchers should note that this mechanism supports preclinical and animal research only—clinical research and clinical trials are not eligible. Applicants must demonstrate preliminary and/or published data from their own research or existing literature, establishing a strong foundation for their proposed work. The award emphasizes measurable impact and tangible advancement in arthritis research translation. This is an excellent opportunity for research teams with promising arthritis-related findings ready to move toward clinical application, particularly those addressing the health challenges faced by military and veteran populations. Organizations with established research capacity and access to relevant preliminary data are encouraged to apply.
Funding Facts
● Applications openDeadline
October 22, 2026
Who can apply
Last verified July 5, 2026 · Source: Grants.gov
Grant Details
Funding Range
Contact program for current funding amounts
Deadline
2026-10-22
Grant Type
federal
Application Cycle
Annual (FY26 cycle; deadline October 22, 2026)
Best For
Research institutions and teams with preliminary arthritis research data ready for translational advancement
Frequently Asked Questions
Who is eligible for DoW Arthritis Translational Research Award?
Specific eligibility criteria have not been provided in the available information. Applicants should consult the official Department of Defense or awarding agency website for detailed eligibility requirements, which typically include institutional affiliation, research credentials, and compliance with federal funding regulations.
How much funding does DoW Arthritis Translational Research Award provide?
Specific funding amounts for this award cycle have not been listed. Applicants should visit the official program website or the Defense.gov grants portal to find current funding levels, budget limits, and award ranges for FY26.
How do I apply for DoW Arthritis Translational Research Award?
Applications for Department of Defense grant programs are typically submitted through official federal portals such as Grants.gov or the Defense.gov research website. For the FY26 cycle, applicants should review the official Funding Opportunity Announcement (FOA) which will include specific submission instructions, required documentation, and any portal-specific guidance. The deadline for this award is October 22, 2026.
What can DoW Arthritis Translational Research Award funding be used for?
This award supports high-impact translational research that accelerates arthritis research findings into clinically relevant solutions. Funding may be used for preclinical and animal research related to any type of arthritis. The award does not support basic research, clinical research, or clinical trials. Applicants must demonstrate how their research outcomes will significantly advance arthritis research and translate findings toward clinical application.
Last updated: July 5, 2026